Pulmonary arterial hypertension (PAH) may occur either as a primary disease of unknown cause [idiopathic PAH (IPAH)] or as an associated manifestation of other diseases or malformations [eg, congenital shunts between the systemic and pulmonary circulation; associated PAH (APAH)].
1- Simonneau G.
- Galie N.
- Rubin L.J.
- Langleben D.
- Seeger W.
- Domenighetti G.
- Gibbs S.
- Lebrec D.
- Speich R.
- Beghetti M.
- Rich S.
- Fishman A.
Clinical classification of pulmonary hypertension.
, 2- Firth A.L.
- Mandel J.
- Yuan J.X.
Idiopathic pulmonary arterial hypertension.
Characteristic histologic findings of PAH include remodeling of small pulmonary arteries and arterioles with varying degrees of endothelial cell proliferation, muscular hypertrophy, and intimal fibrosis, ultimately leading to an obliteration of precapillary vessels. Morphologic hallmarks of severe PAH are the so-called plexiform lesions (PLs): complex, glomeruloid-like vascular structures originating from the pulmonary arteries.
3- Sakao S.
- Tatsumi K.
- Voelkel N.F.
Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation.
, 4- Pietra G.G.
- Edwards W.D.
- Kay J.M.
- Rich S.
- Kernis J.
- Schloo B.
- Ayres S.M.
- Bergofsky E.H.
- Brundage B.H.
- Detre K.M.
Histopathology of primary pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.
Whether PLs represent just a morphologic “indicator lesion” or play a role in the pathogenesis and/or progression of PAH has not yet been clarified. On a more basal level, even the actual cellular composition of PLs has not been conclusively determined: the high plasticity of the (mesenchymal) cells involved, ie, their ability to change their phenotype depending on the current local microenvironment, have hampered analysis.
5Molecular and cellular determinants of lung endothelial cell heterogeneity.
, 6- Owens G.K.
- Kumar M.S.
- Wamhoff B.R.
Molecular regulation of vascular smooth muscle cell differentiation in development and disease.
The favored consensus describes the PL as a proliferating network of endothelial-lined vascular channels supported by a core of specialized and apoptosis-resistant myofibroblasts, smooth muscle cells, or even undifferentiated mesenchymal cells.
7- Cool C.D.
- Stewart J.S.
- Werahera P.
- Miller G.J.
- Williams R.L.
- Voelkel N.F.
- Tuder R.M.
Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers: evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.
Animal models using chronic hypoxia combined with the application of SU5416 (semaxinib), a vascular endothelial growth factor receptor (VEGFR) blocker, have produced glomeruloid lesions that mimic the formation of PLs to a certain extent.
8- Abe K.
- Toba M.
- Alzoubi A.
- Ito M.
- Fagan K.A.
- Cool C.D.
- Voelkel N.F.
- McMurtry I.F.
- Oka M.
Formation of plexiform lesions in experimental severe pulmonary arterial hypertension.
These lesions develop early after treatment with SU5416 combined with hypoxia, a situation that does not fully mirror the situation in humans, where there is evidence that severe pulmonary arterial pressure over a longer period is needed to induce PLs.
9- Abe M.
- Kimura T.
- Morimoto T.
- Taniguchi T.
- Yamanaka F.
- Nakao K.
- Yagi N.
- Kokubu N.
- Kasahara Y.
- Kataoka Y.
- Otsuka Y.
- Kawamura A.
- Miyazaki S.
- Horiuchi K.
- Ito A.
- Hoshizaki H.
- Kawaguchi R.
- Setoguchi M.
- Inada T.
- Kishi K.
- Sakamoto H.
- Morioka N.
- Imai M.
- Shiomi H.
- Nonogi H.
- Mitsudo K.
Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: insights from the j-Cypher Registry.
Moreover, neoangiogenesis in peritumoral tissue, such as the so-called glomeruloid-like lesions (GLLs) in high-grade neural tumors, have also been discussed as a putative model for PLs.
10Plexiform lesion in severe pulmonary hypertension: association with glomeruloid lesion.
, 11- Skuli N.
- Liu L.
- Runge A.
- Wang T.
- Yuan L.
- Patel S.
- Iruela-Arispe L.
- Simon M.C.
- Keith B.
Endothelial deletion of hypoxia-inducible factor-2α (HIF-2α) alters vascular function and tumor angiogenesis.
, 12The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension.
, 13- Tuder R.M.
- Groves B.
- Badesch D.B.
- Voelkel N.F.
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.
This experimental approach is compatible with the concept of the PL, or rather the adjacent artery from which it arises, as a circumscript angiogenic reservoir or niche that accommodates endothelial cells with a “quasi neoplastic” behavior, which contributes to remodeling of the pulmonary vasculature.
14- Rai P.R.
- Cool C.D.
- King J.A.
- Stevens T.
- Burns N.
- Winn R.A.
- Kasper M.
- Voelkel N.F.
The cancer paradigm of severe pulmonary arterial hypertension.
Thus, although extensive analyses have been performed in animal experiments or alternative, tumor-associated vascular models that show a degree of morphologic similarity, actual PLs in humans have not yet been studied in more detail.
In this work, we studied the cellular composition, architecture, and local signaling of PLs in human PAH lungs. We compared the microenvironment in PLs with that in tumor-associated GLLs to examine the relevance of neoplastic models as a research platform for PLs. Furthermore, we aimed to explore whether PLs represent an epiphenomenon in severe PAH and whether the “angiogenic niche” plays a major role in vascular remodeling.
Discussion
Complex vascular formations, so-called PLs, are histologic hallmarks of lungs from patients with PAH. Whether they represent morphologic sequelae of the raised intravascular pressure or actively contribute to the course of the disease is still debated;
per se, both seem possible.
22Changing concepts of the pulmonary plexiform lesion.
, 23- Crosby A.
- Jones F.M.
- Southwood M.
- Stewart S.
- Schermuly R.
- Butrous G.
- Dunne D.W.
- Morrell N.W.
Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis.
, 24- Toshner M.
- Voswinckel R.
- Southwood M.
- Al-Lamki R.
- Howard L.S.
- Marchesan D.
- Yang J.
- Suntharalingam J.
- Soon E.
- Exley A.
- Stewart S.
- Hecker M.
- Zhu Z.
- Gehling U.
- Seeger W.
- Pepke-Zaba J.
- Morrell N.W.
Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension.
PLs are generally thought to originate from a misled neoangiogenesis with a dysbalance between apoptosis/necrosis and subsequent proliferation of the endothelium.
3- Sakao S.
- Tatsumi K.
- Voelkel N.F.
Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation.
Although PLs and their development over time have been studied in animal experiments and in part in
in vitro settings, knowledge about PLs in the human lung is still limited.
Although they are end-stage organs, recipient lung explants sampled at the date of transplantation represent the only feasible source of lung tissue with characteristic histologic changes of severe PAH in humans. Transbronchial or wedge biopsies are not obtained in day-to-day routine from patients with PAH; in fact, for the most part, the latter are contraindicated owing to considerable bleeding risk, and material taken during postmortem examinations is usually unsuitable for an extensive molecular workup.
From a morphologic point of view, using fluorescent double staining and regular IHC analysis and 3-D reconstruction, these results reveal that PLs are highly ordered structures. The thin, luminal layer around vascular channels was composed of a homogeneous population of CD31-, CD34-, and CD141-positive endothelial cells. This concurs with the mRNA up-regulation of CD31 and endothelial nitric oxide synthase, which suggests prominent endothelial differentiation and further extends previous findings describing endothelial cells as the predominant, if not only, cell type composing PLs. We found no thrombi in any of the PLs we examined. This suggests an intact intima/endothelium with a predominantly nonturbulent flow.
5Molecular and cellular determinants of lung endothelial cell heterogeneity.
We also found a distinct interstitial compartment in PLs, separating the individual blood channels from each other. It was composed of a thin, uniform layer of mesenchymal cells with myogenic differentiation (“interstitial cells of myogenic phenotype”). These cells showed prominent up-regulation of SMA, even compared with the adjacent remodeled arteries, which had prominent media and intima and, thus, consisted mainly of smooth muscle cells. There was, however, only limited expression of smmhc and, notably, desmin. As the concentration of these intermediary filament increases with advancing differentiation of smooth muscle cells toward a contractile phenotype,
25- Rensen S.S.
- Doevendans P.A.
- van Eys G.J.
Regulation and characteristics of vascular smooth muscle cell phenotypic diversity.
, 26Mechanisms of vascular smooth muscle cell migration.
we consider the heterogeneous expression pattern an indicator of an intermediate state between the contractile and synthetic phenotypes, a finding that is consistent with IHC staining patterns described by others in postmortem case studies in lungs of patients with PAH.
27- Mitani Y.
- Ueda M.
- Komatsu R.
- Maruyama K.
- Nagai R.
- Matsumura M.
- Sakurai M.
Vascular smooth muscle cell phenotypes in primary pulmonary hypertension.
Whereas synthetic differentiation tends toward increased proliferation and migration, the contractile phenotype is associated with structural integrity. Both are needed for progressive vascular remodeling.
25- Rensen S.S.
- Doevendans P.A.
- van Eys G.J.
Regulation and characteristics of vascular smooth muscle cell phenotypic diversity.
Because remodeling in PAH lungs affects all precapillary vascular compartments, from the truncus pulmonalis down to the arterioles, the question arises as to why the remodeling process is especially pronounced and intricate in PLs. The low expression levels of myocardin and smmhc (but not of β-type platelet-derived growth factor receptor) in PLs might provide an answer: these three proteins are characteristic of pericytes. In this line, knockout experiments showed that the absence of these regulatory perivascular cells indeed promotes abundant endothelial hyperplasia in smaller vessels.
28- Jones R.
- Capen D.
- Jacobson M.
PDGF and microvessel wall remodeling in adult lung: imaging PDGF-Rβ and PDGF-BB molecules in progenitor smooth muscle cells developing in pulmonary hypertension.
, 29- Assaad A.M.
- Kawut S.M.
- Arcasoy S.M.
- Rosenzweig E.B.
- Wilt J.S.
- Sonett J.R.
- Borczuk A.C.
Platelet-derived growth factor is increased in pulmonary capillary hemangiomatosis.
, 30- Zhu P.
- Huang L.
- Ge X.
- Yan F.
- Wu R.
- Ao Q.
Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle-like cells regulated by myocardin involved in hypoxia-induced pulmonary vascular remodelling.
A possible “outgrowth” of the vascular channels in PLs, with which the regulatory pericytes did not keep pace, might lead to a relative lack of pericytes in PLs. Thus, aside from local hypoxia and shear forces, lack of superordinate regulation might contribute to the ongoing remodeling in PAH lungs. Because pericytes possess considerable plasticity, they cannot be definitely characterized by mRNA and protein expression, thus severely hampering the analysis of their involvement in the formation of PLs.
31The pericyte: cellular regulator of microvascular blood flow.
, 32- Kennedy A.
- Ng C.T.
- Biniecka M.
- Saber T.
- Taylor C.
- O'Sullivan J.
- Veale D.J.
- Fearon U.
Angiogenesis and blood vessel stability in inflammatory arthritis.
, 33- Raza A.
- Franklin M.J.
- Dudek A.Z.
Pericytes and vessel maturation during tumor angiogenesis and metastasis.
We repeatedly found delicate networks of lymphatic vessels surrounding the PLs, mainly populated by T lymphocytes, presumably identical to “clusters of inflammatory cells” identified by others.
34- Angelini D.J.
- Su Q.
- Yamaji-Kegan K.
- Fan C.
- Teng X.
- Hassoun P.M.
- Yang S.C.
- Champion H.C.
- Tuder R.M.
- Johns R.A.
Resistin-like molecule-β in scleroderma-associated pulmonary hypertension.
, 35Pulmonary hypertension in autoimmune rheumatic diseases.
In the PL, no lymphatics could be shown. Although elevated serum levels of ILs in patients with PAH have been described, there was no increased expression of ILs in the vascular compartments examined.
36- Hecker M.
- Zaslona Z.
- Kwapiszewska G.
- Niess G.
- Zakrzewicz A.
- Hergenreider E.
- Wilhelm J.
- Marsh L.M.
- Sedding D.
- Klepetko W.
- Lohmeyer J.
- Dimmeler S.
- Seeger W.
- Weissmann N.
- Schermuly R.T.
- Kneidinger N.
- Eickelberg O.
- Morty R.E.
Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension.
Although these specimens represent end-stage organs in severely ill patients, PLs still displayed a marked degree of ongoing remodeling. There was pronounced proliferation of endothelial cells, but we observed only a limited extent of cell division in the muscular interstitium. We found almost no detectable apoptosis in either cell type. This concurs with findings of others, who postulate PLs as a result of focal arterial wall apoptosis/necrosis. This initial selection process is thought to leave a circumscript aggregate or remnant of apoptosis-resistant endothelial cells, which compose and promote the growth and reshaping of PLs.
3- Sakao S.
- Tatsumi K.
- Voelkel N.F.
Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation.
This continuous proliferation with invagination and sprouting of vascular channels was mirrored by an increased expression of MMP9 and NOTCH4. Of these, the former is involved in the remodeling of the basement membrane during the sprouting process and the latter is involved in the cross talk with pivotal VEGF-α and TGF-β1, the smooth muscle layers and the endothelium, which also drives the reshaping of the local vasculature.
37- van Hinsbergh V.W.
- Koolwijk P.
Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead.
, 38- Holderfield M.T.
- Hughes C.C.
Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-β in vascular morphogenesis.
, 39- Merks R.M.
- Perryn E.D.
- Shirinifard A.
- Glazier J.A.
Contact-inhibited chemotaxis in de novo and sprouting blood-vessel growth.
The tissue remodeling–associated microenvironment in PLs in PAH is complex. We found significant up-regulation of hypoxia and shear stress–induced angiogenic mediators, such as HIF1a, VEGF-α and its corresponding receptors (VEGFR1 and VEGFR2), Ang-1, Tie-2, and THBS1 but also of c-KIT in PLs. Considering the importance of these pathways for angiogenesis in general, and particularly for the remodeling of the pulmonary blood vessels, up-regulation in PAH lungs
per se is principally not surprising. These markers have been demonstrated to be elevated in different organs and the peripheral bloodstream of patients with PAH and in animal models, where especially the induction of the VEGF pathway correlated with the severity of PAH and, accordingly, survival.
40- Ochoa C.D.
- Yu L.
- Al-Ansari E.
- Hales C.A.
- Quinn D.A.
Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension.
, 41- Liu A.
- Mosher D.F.
- Murphy-Ullrich J.E.
- Goldblum S.E.
The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia.
, 42- Papaioannou A.I.
- Zakynthinos E.
- Kostikas K.
- Kiropoulos T.
- Koutsokera A.
- Ziogas A.
- Koutroumpas A.
- Sakkas L.
- Gourgoulianis K.I.
- Daniil Z.D.
Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis.
, 43- Kumpers P.
- Nickel N.
- Lukasz A.
- Golpon H.
- Westerkamp V.
- Olsson K.M.
- Jonigk D.
- Maegel L.
- Bockmeyer C.L.
- David S.
- Hoeper M.M.
Circulating angiopoietins in idiopathic pulmonary arterial hypertension.
, 44- Ito C.
- Akimoto T.
- Ioka T.
- Kobayashi T.
- Kusano E.
TGF-β inhibits vascular sprouting through TGF-β type I receptor in the mouse embryonic aorta.
Their concerted up-regulation in PLs, especially compared with the adjacent remodeled arteries/concentric lesions, is, however, interesting. Although it is unlikely that lesions that arise as late in the course of a disease as PLs do in PAH,
9- Abe M.
- Kimura T.
- Morimoto T.
- Taniguchi T.
- Yamanaka F.
- Nakao K.
- Yagi N.
- Kokubu N.
- Kasahara Y.
- Kataoka Y.
- Otsuka Y.
- Kawamura A.
- Miyazaki S.
- Horiuchi K.
- Ito A.
- Hoshizaki H.
- Kawaguchi R.
- Setoguchi M.
- Inada T.
- Kishi K.
- Sakamoto H.
- Morioka N.
- Imai M.
- Shiomi H.
- Nonogi H.
- Mitsudo K.
Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: insights from the j-Cypher Registry.
and by no means occur in every patient with PAH,
4- Pietra G.G.
- Edwards W.D.
- Kay J.M.
- Rich S.
- Kernis J.
- Schloo B.
- Ayres S.M.
- Bergofsky E.H.
- Brundage B.H.
- Detre K.M.
Histopathology of primary pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.
are involved in the onset of the condition, they might well contribute to its sustainment as a source of mediators guiding vascular remodeling in other anatomic sites of the lung.
In contrast, the universally low mitotic rate and low expression of angiogenic/remodeling-associated markers in the arteries from which PLs arise do not support the concept of a circumscript “angiogenic niche” that harbors cells with a quasi neoplastic behavior in these adjacent vessels. Rather, we consider the sprouting of PLs to be an overshooting regenerative process and not a neoplastic event sensu stricto.
Significant up-regulation of hypoxemia-induced genes in the control group is explained by the cold ischemia to which the grafts, from which the downsizing-specimens were sampled before transplantation, were exposed while being transported to and prepared for the organ recipient.
45- Jayle C.
- Favreau F.
- Zhang K.
- Doucet C.
- Goujon J.M.
- Hebrard W.
- Carretier M.
- Eugene M.
- Mauco G.
- Tillement J.P.
- Hauet T.
Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: early and long-term effects in a pig kidney model.
, 46- Lario S.
- Bescos M.
- Campos B.
- Mur C.
- Luque P.
- Alvarez R.
- Campistol J.M.
Thrombospondin-1 mRNA expression in experimental kidney transplantation with heart-beating and non-heart-beating donors.
Recipient lungs with hypertension-induced changes, on the other hand, did not undergo cold ischemia but were fixated directly after explantation.
We found significant up-regulation of BMP-4 and BMPR2 in concentric lesions in remodeled pulmonary arteries of patients with APAH but not in cases with PLs. These proteins were originally named for their ability to facilitate bone tissue formation, but more recently their involvement in the signaling balance in lung development and fibrosis has been demonstrated: whereas the cross talk between BMPs and other members of the TGF superfamily is yet to be fully elucidated, various interactions, such as shared receptors and competition for subordinate SMADs, have been described, which for the most part serve the maintenance of tissue homeostasis.
47- Pegorier S.
- Campbell G.A.
- Kay A.B.
- Lloyd C.M.
Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-β1 in normal human lung fibroblasts (NHLF).
Elevated but also decreased levels of BMPs have been described in patients with tissue remodeling in different organs, and
in vitro studies have attributed BMPs with a degree of protective properties.
48- Wang S.
- de Caestecker M.
- Kopp J.
- Mitu G.
- Lapage J.
- Hirschberg R.
Renal bone morphogenetic protein-7 protects against diabetic nephropathy.
, 49- Reynolds A.M.
- Xia W.
- Holmes M.D.
- Hodge S.J.
- Danilov S.
- Curiel D.T.
- Morrell N.W.
- Reynolds P.N.
Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension.
In the lung, aberrant BMP expression due to inactivation of the
BMPR2 gene has been shown to lead to a disorganized proliferation of smooth muscle cells and to contribute to the development of PAH.
50- Machado R.D.
- Eickelberg O.
- Elliott C.G.
- Geraci M.W.
- Hanaoka M.
- Loyd J.E.
- Newman J.H.
- Phillips III, J.A.
- Soubrier F.
- Trembath R.C.
- Chung W.K.
Genetics and genomics of pulmonary arterial hypertension.
Although the pathophysiologic significance of the BMPR2 mutation in IPAH has been proved, we could not find an effect on the morphology and composition of PLs.
Because neoangiogenesis in high-grade glial neoplasms (so-called GLLs) and PLs share a related morphology, they have been proposed as a putative model for PLs.
10Plexiform lesion in severe pulmonary hypertension: association with glomeruloid lesion.
, 51- Ricci-Vitiani L.
- Pallini R.
- Biffoni M.
- Todaro M.
- Invernici G.
- Cenci T.
- Maira G.
- Parati E.A.
- Stassi G.
- Larocca L.M.
- De Maria R.
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.
In (fluorescent) IHC staining, we found blood vessels in GLLs to have a prominent variation in thickness and layering compared with PLs. A continuous myogenic layer separating the endothelium of individual channels was not always discernible in GLLs. Furthermore, compared with GLLs, PLs showed significant up-regulation of desmin, myocardin, and smmhc (but not of SMA). Thus, according to the yardstick discussed previously herein, smooth muscle cells in GLLs show a different phenotypic differentiation than do PLs.
25- Rensen S.S.
- Doevendans P.A.
- van Eys G.J.
Regulation and characteristics of vascular smooth muscle cell phenotypic diversity.
With an up-regulation of Ang-2 and Tie-2 in PLs, but Ang-2 and VEGFR2 in GLLs, remodeling-associated markers also differed significantly. Because of these apparent differences, we feel that neoplastic models, such as GLLs, will be of limited use in the further study of plexiform vasculopathy.
In conclusion, we found PLs to be well-organized structures with a distinct microenvironment that sets them apart from the remodeled arteries in PAH lungs. The present results imply that PLs represent a complex, multifactorial epiphenomenon with shared characteristics in APAH and IPAH. Aside from studies in the human setting, preference should be given to animal models, which, in contrast to neoplastic models, can depict the hemodynamic aspects of PAH.
52- Stenmark K.R.
- Meyrick B.
- Galie N.
- Mooi W.J.
- McMurtry I.F.
Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure.
Article info
Publication history
Published online: May 12, 2011
Accepted:
March 29,
2011
Footnotes
Supported by the “Integriertes Forschungs-und Behandlungszentrum Transplantation” [German Federal Ministry of Education (reference no. 01EO0802)], by the European Commission under the 6th Framework Program (reference no. LSHM-CT-2005-018725, PULMOTENSION), and by the Deutsche Forschungsgemeinschaft, SFB-Transregio-37/project B4.
D.J. and H.G. contributed equally to this work.
Supplemental material for this article can be found at http://ajp.amjpathol.org or at doi: 10.1016/j.ajpath.2011.03.040.
Copyright
© 2011 American Society for Investigative Pathology. Published by Elsevier Inc.